Post job

Competitor Summary. See how LifeMine compares to its main competitors:

  • Voyager Therapeutics has the most employees (123).
  • The oldest company is Onconova Therapeutics, founded in 1998.
Work at LifeMine?
Share your experience

LifeMine vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2017
4.1
Cambridge, MA1$1.4M108
2015
4.3
Cambridge, MA1$2.6M60
Sapience Therapeutics
2015
3.6
Scarsdale, NY1$510,00015
2016
4.4
Cambridge, MA1$3.4M73
Rgenta Therapeutics
2018
3.3
Cambridge, MA1$41,0005
2010
4.6
Cambridge, MA1$19.6M35
2012
4.5
San Francisco, CA1$54.5M103
2013
4.5
Cambridge, MA1$80.0M123
Onconova Therapeutics
1998
3.4
Newtown, PA3$226,00012
2014
4.5
South San Francisco, CA1$450.9M61

Rate how well LifeMine differentiates itself from its competitors.

Zippia waving zebra

LifeMine salaries vs competitors

Compare LifeMine salaries vs competitors

CompanyAverage salaryHourly salarySalary score
LifeMine
$91,690$44.08-

Compare LifeMine job title salaries vs competitors

CompanyHighest salaryHourly salary
LifeMine
$79,724$38.33
Sesen Bio
$80,571$38.74
KSQ Therapeutics
$80,562$38.73
FogPharma
$80,549$38.73
Sapience Therapeutics
$80,515$38.71
Rgenta Therapeutics
$80,505$38.70
Voyager Therapeutics
$80,248$38.58
Nurix
$80,112$38.52
Onconova Therapeutics
$79,668$38.30
ORIC Pharmaceuticals
$79,615$38.28

Do you work at LifeMine?

Is LifeMine able to compete effectively with similar companies?

LifeMine jobs

LifeMine demographics vs competitors

Compare gender at LifeMine vs competitors

Job titleMaleFemale
Onconova Therapeutics63%38%
LifeMine--
Male
Female
100%
75%
50%
25%
0%

LifeMine

Onconova Therapeutics

0%
25%
50%
75%
100%

Compare race at LifeMine vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
Onconova Therapeutics
49%12%12%26%1%
6.6

LifeMine and similar companies CEOs

CEOBio
Thomas Cannell
Sesen Bio

Barry Kappel
Sapience Therapeutics

Barry Kappel is a Board Member at Sapience Therapeutics Inc and Founder, President and CEO at Sapience Therapeutics Inc and is based in New York City, New York. He has worked as Senior Consultant at Easton Associates, Senior Vice President Business Development at CONTRAFECT CORP, and Lab Manager and Senior Research Technician at Memorial Sloan - Kettering Cancer Center. Barry attended Emory University between 1994 and 1998 and Cornell between 2006 and 2007.

Qasim Rizvi
KSQ Therapeutics

Qasim Rizvi is the Senior Vice President of Operations and Chief Commercial Officer at Kiniksa Pharmaceuticals.

Simon Xi
Rgenta Therapeutics

Simon Xi is the Co-Founder and Chief Executive Officer of Rgenta. He has 20 years of drug discovery experience in top pharmaceutical companies and academic institutes. Simon helped conceptualize the initial scientific strategy for Rgenta and has led the development of the discovery platform since its launch. Prior to Rgenta, Simon was the head of the genomics and compbio group at Abbvie foundational neuroscience center where he established the genomics platform and compbio function for target discovery and validation. Before Rgenta, Simon was an accomplished scientist and group leader at Pfizer with increasing responsibilities. During his time at Pfizer, Simon has led multiple novel therapeutics targets into the discovery portfolio and established close collaborations with academic institutions. Simon co-authored more than 30 research publications and is currently an adjunct faculty at Brandeis University and a principal investigator in the GTEx Consortium.

Gregory L. Verdine
FogPharma

LifeMine competitors FAQs

Search for jobs